Yeoh Su Ying, Roberts Emmert, Scott Fraser, Nicholson Timothy R, David Anthony S, Rogers Jonathan P
South London and Maudsley NHS Foundation Trust, London, UK.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
J Dual Diagn. 2022 Jan-Mar;18(1):52-58. doi: 10.1080/15504263.2021.2016342. Epub 2022 Jan 8.
Substance use has increasingly been linked to the onset of catatonic episodes; however, no large observational studies have examined this association. This study aimed to identify catatonic episodes temporally associated with acute intoxication, withdrawal or chronic substance use, investigate which substances were involved, and compare clinical characteristics of substance-related and non-substance-related catatonic episodes. This study retrospectively identified all catatonic episodes recorded in an electronic case register hosted at a large secondary mental health trust in London, UK. Episodes were categorized as substance-related if the clinical record reported either a positive urine drug screen, an ICD-10 diagnosis of a mental or behavioral disorder due to substance use, or documented substance use between two weeks prior to the catatonic episode and the date of the catatonic episode. 108 of 2130 catatonic episodes (5.1%) were deemed substance-related. The number of contemporaneously reported substance-related episodes increased between 2007 and 2016 [ = 0.72, = 0.02]. Episodes in the context of acute intoxication ( = 54) were most frequently related to cannabis ( = 31) or cocaine ( = 5) use, whilst those in the context of drug withdrawal ( = 8) were most commonly related to alcohol, opioids and benzodiazepines. There were 50 episodes of catatonia associated with chronic substance use without intoxication or withdrawal, of which the majority were related to cannabis use ( = 37). 21 episodes had overlapping intoxication, withdrawal and chronic use of different substances within an episode. Compared to catatonic episodes not related to substance use, episodes of substance-related catatonia occurred in individuals who were younger (mean age 31.3 years [SD 12.2] vs 35.7 years [SD 16.3], = 0.01) and more likely to be men (74.0% vs 54.3%, < 0.001). The clinical features of catatonia were similar between the two groups. A relatively small proportion of catatonic episodes were temporally associated with reported substance use within their electronic records. Substance-related catatonic episodes were mostly related to cannabis use, but other substances including cocaine, alcohol, opioids and benzodiazepines were sometimes implicated. This is likely an underestimate of substance-related catatonia use due to issues with documentation and appropriate investigation.
物质使用与紧张症发作的关联日益增加;然而,尚无大型观察性研究对此关联进行考察。本研究旨在确定与急性中毒、戒断或慢性物质使用在时间上相关的紧张症发作,调查涉及哪些物质,并比较与物质相关和与物质无关的紧张症发作的临床特征。本研究回顾性地确定了英国伦敦一家大型二级心理健康信托机构维护的电子病例登记册中记录的所有紧张症发作。如果临床记录报告尿液药物筛查呈阳性、因物质使用导致的精神或行为障碍的ICD - 10诊断,或在紧张症发作前两周至紧张症发作日期之间有记录的物质使用,则将发作分类为与物质相关。2130例紧张症发作中有108例(5.1%)被认为与物质相关。2007年至2016年期间同期报告的与物质相关的发作数量有所增加[= 0.72,= 0.02]。急性中毒情况下的发作(= 54)最常与大麻使用(= 31)或可卡因使用(= 5)有关,而戒断情况下的发作(= 8)最常与酒精、阿片类药物和苯二氮䓬类药物有关。有50例紧张症发作与慢性物质使用相关,无中毒或戒断情况,其中大多数与大麻使用有关(= 37)。21例发作在一次发作中存在不同物质的重叠中毒、戒断和慢性使用情况。与与物质使用无关的紧张症发作相比,与物质相关的紧张症发作发生在更年轻的个体中(平均年龄31.3岁[标准差12.2]对35.7岁[标准差16.3],= 0.01),且更可能为男性(74.0%对54.3%,< 0.001)。两组之间紧张症的临床特征相似。在其电子记录中,相对较小比例的紧张症发作在时间上与报告的物质使用相关。与物质相关的紧张症发作大多与大麻使用有关,但有时也涉及包括可卡因、酒精、阿片类药物和苯二氮䓬类药物在内的其他物质。由于记录和适当调查方面的问题,这可能低估了与物质相关的紧张症的使用情况。